Title : Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy.

Pub. Date : 2004 Jan

PMID : 14592851






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Cholesterol paraoxonase 2 Homo sapiens
2 Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Atorvastatin paraoxonase 2 Homo sapiens
3 OBJECTIVE: To analyze paraoxonase2 (PON2) expression in human monocyte-derived macrophages (HMDM) from patients with hypercholesterolemia in relation to cellular cholesterol and oxidative stress. Cholesterol paraoxonase 2 Homo sapiens
4 OBJECTIVE: To analyze paraoxonase2 (PON2) expression in human monocyte-derived macrophages (HMDM) from patients with hypercholesterolemia in relation to cellular cholesterol and oxidative stress. Cholesterol paraoxonase 2 Homo sapiens
5 CONCLUSIONS: HMDM-PON2 expression is reduced in patients with hypercholesterolemia as a result of their increased cellular cholesterol content. Cholesterol paraoxonase 2 Homo sapiens
6 Atorvastatin therapy reduced both macrophage oxidative stress and cholesterol content, and upregulated PON2 expression, thus contributing to attenuation of foam cells formation. Atorvastatin paraoxonase 2 Homo sapiens